01 May 2020 --- Supplementation with BASF Human Nutrition’s newly launched brand of 2’-FL, called Prebilac, can lead to compositional changes in the gut microbiota associated with reduced body weight. This is according to a new study supported by the Germany-based company, which found that the human milk oligosaccharide (HMO) blend can shift gut microbiota dysbiosis toward a more positive state, presenting an attractive potential avenue for obesity treatment. Meanwhile, BASF Group’s Q1 results reveal growth in its Nutrition & Care segment, although overall business goals for 2020 are no longer deemed feasible to achieve.
